1. Effects of supervised exercise during adjuvant endocrine therapy in overweight or obese patients with breast cancer: The I-MOVE study
- Author
-
Annette W.G. van der Velden, Jourik A. Gietema, Aline H. Vrieling, Harm L Ormel, Carolina P. Schröder, Annemiek M E Walenkamp, Gabriela G. F. van der Schoot, Anna K.L. Reyners, Boelo Jan Poppema, Nico-Derk L. Westerink, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), and Targeted Gynaecologic Oncology (TARGON)
- Subjects
Endocrine therapy ,medicine.medical_specialty ,PHYSICAL-ACTIVITY LEVELS ,Breast Neoplasms ,Overweight ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Quality of life ,QUALITY-OF-LIFE ,Internal medicine ,medicine ,Clinical endpoint ,Humans ,Clinical significance ,030212 general & internal medicine ,Obesity ,RESISTANCE EXERCISE ,PREDICTORS ,Exercise ,RC254-282 ,METABOLIC SYNDROME ,SURVIVORS ,business.industry ,Physical activity ,WOMEN ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,General Medicine ,Guideline ,Middle Aged ,medicine.disease ,Exercise Therapy ,Clinical trial ,Oncologic rehabilitation ,030220 oncology & carcinogenesis ,COMPARABILITY ,Quality of Life ,Surgery ,Original Article ,Female ,Metabolic syndrome ,medicine.symptom ,business ,BEHAVIOR ,INTERVENTIONS - Abstract
Background Adjuvant endocrine therapy (ET) in patients with breast cancer (BC) increases the risk of becoming less physically active. Physical inactivity is associated with a higher risk of treatment-related side effects and mortality. This study investigated whether supervised exercise increased the proportion of patients adhering to the national physical activity (PA) guideline during adjuvant ET in overweight or obese BC patients. Methods This multicentre single-arm clinical trial included patients with BC participating in a 12-week supervised exercise intervention. An accelerometer measured moderate to vigorous PA (MVPA) at baseline (T0), after 12 (T1) and 26 weeks (T2). The primary endpoint was change in the proportion of patients with weekly ≥150 min of MVPA at T1 compared to T0. Secondary endpoints were adherence to PA guideline at T2, metabolic syndrome (MetS), body composition, health-related quality of life (HRQoL) and BC-specific functioning and symptoms, self-reported PA, self-efficacy, exercise motivation and satisfaction with life. Results 141 patients with a median age of 61 years and a mean BMI of 31.3 participated. Adherence to the PA guideline increased from 38.3% at T0, to 40.4% at T1 (p = .112) and 44.7% at T2 (p = .003). MetS, body composition, HRQoL, BC-specific functioning and symptoms (i.e. fatigue, dyspnoea), self-reported PA, self-efficacy, exercise motivation and satisfaction with life improved significantly over time. Conclusions Supervised exercise increased the proportion of BC patients adhering to the PA guideline over time. Furthermore, MetS, body composition, HRQoL and symptoms improved. Our findings highlight the clinical relevance of supervised exercise during ET in overweight BC patients. Clinical trial information (NCT02424292)., Highlights • Overweight breast cancer patients on endocrine therapy can be motivated for supervised exercise. • Supervised exercise increases adherence to the physical activity guideline. • Metabolic syndrome and quality of life improved due to our intervention. • Participation in supervised exercise induces persistent clinical improvements.
- Published
- 2021